Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: differential effect of antidepressant treatment.

BACKGROUND Brain α2- and β-adrenoceptor alterations have been suggested in suicide and major depressive disorder. METHODS The densities of α2-, β1- and β2-adrenoceptors in postmortem prefrontal cortex of 26 subjects with depression were compared with those of age-, gender- and postmortem delay-matched controls. The effect of antidepressant treatment on α2- and β-adrenoceptor densities was also evaluated. α2- and β-adrenoceptor densities were measured by saturation experiments with respective radioligands [(3)H]UK14304 and [(3)H]CGP12177. β1- and β2-adrenoceptor subtype densities were dissected by means of β1-adrenoceptor selective antagonist CGP20712A. RESULTS Both, α2- and β1-adrenoceptors densities were higher in antidepressant-free depressed subjects (n=14) than those in matched controls (Δ~24%, p=0.013 and Δ~20%, p=0.044, respectively). In antidepressant-treated subjects (n=12), α2-adrenoceptor density remained increased over that in controls (Δ~20%), suggesting a resistance of α2-adrenoceptors to the down-regulatory effect of antidepressants. By contrast, β1-adrenoceptor density in antidepressant-treated depressed subjects was not different from controls, suggesting a possible down-regulation by antidepressants. The down-regulation of β1-adrenoceptor density in antidepressant-treated depressed subjects differs from the unaltered β1-adrenoceptor density observed in citalopram-treated rats and in a group of non-depressed subjects also treated with antidepressants (n=6). β2-adrenoceptor density was not altered in depressed subjects independently of treatment. LIMITATIONS Antidepressant-treated subjects had been treated with a heterogeneous variety of antidepressant drugs. The results should be understood in the context of suicide victims with depression. CONCLUSIONS These results show the up-regulation of brain α2- and β1-adrenoceptors in depression and suggest that the regulation induced by chronic antidepressant treatment would be altered in these subjects.

[1]  Á. Pazos,et al.  Adenylate cyclase activity in postmortem brain of suicide subjects: reduced response to β-adrenergic stimulation , 2003, Biological Psychiatry.

[2]  Anat Biegon,et al.  Regionally selective increases in μ opioid receptor density in the brains of suicide victims , 1990, Brain Research.

[3]  F. Sulser,et al.  Electroconvulsive treatment: rapid subsensitivity of the norepinephrine receptor coupled adenylate cyclase system in brain linked to down regulation of beta-adrenergic receptors. , 1979, Communications in psychopharmacology.

[4]  C. Katona,et al.  Brain α-adrenoceptors in depressed suicides , 1997, Brain Research.

[5]  L. Frölich,et al.  Imbalance of the Gs and Gi/o function in post-mortem human brain of depressed patients , 2005, Journal of Neural Transmission / General Section JNT.

[6]  J. García-Sevilla,et al.  α2-Adrenoreceptors in rat brain are decreased after long-term tricyclic antidepressant drug treatment , 1981, Brain Research.

[7]  J. Guimón,et al.  Up‐Regulation of Immunolabeled α2A‐Adrenoceptors, Gi Coupling Proteins, and Regulatory Receptor Kinases in the Prefrontal Cortex of Depressed Suicides , 1999, Journal of neurochemistry.

[8]  J. Vetulani,et al.  Attenuation by chronic imipramine treatment of [3H]clonidine binding to cortical membranes and of clonidine-induced hypothermia: the influence of central chemosympathectomy , 1982, Brain Research.

[9]  J. Guimón,et al.  Regulation of Platelet α2A-Adrenoceptors, Gi Proteins and Receptor Kinases in Major Depression: Effects of Mirtazapine Treatment , 2004, Neuropsychopharmacology.

[10]  C. Gambarana,et al.  Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments. , 1991, The Journal of pharmacology and experimental therapeutics.

[11]  J. Pineda,et al.  α2-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons , 2005 .

[12]  M. Sastre,et al.  Opposite Age‐Dependent Changes of α2A‐Adrenoceptors and Nonadrenoceptor [3H]Idazoxan Binding Sites (I2‐Imidazoline Sites) in the Human Brain: Strong Correlation of I2 with Monoamine Oxidase‐B Sites , 1993, Journal of neurochemistry.

[13]  J. García-Sevilla,et al.  Acute and long-term regulation of brain alpha 2-adrenoceptors after manipulation of noradrenergic transmission in the rat. , 1989, European journal of pharmacology.

[14]  W. May,et al.  Elevated agonist binding to α2-adrenoceptors in the locus coeruleus in major depression , 2003, Biological Psychiatry.

[15]  A. Lau,et al.  Heterodimerization of α2A- and β1-Adrenergic Receptors* , 2003, The Journal of Biological Chemistry.

[16]  A. Rush,et al.  Platelet alpha2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome , 1999, Psychiatry Research.

[17]  J. Guimón,et al.  Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of α2A-adrenoceptors , 2002, Molecular Psychiatry.

[18]  P. Van Eenoo,et al.  beta-Adrenergic stimulation. , 2010, Handbook of experimental pharmacology.

[19]  E. Bürgisser Chapter 14 – β-ADRENERGIC RECEPTORS , 1984 .

[20]  M. Gobbi,et al.  Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic α2-adrenoceptors , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[21]  K. Jiao,et al.  Cross-talk from β-Adrenergic Receptors Modulates α2A-Adrenergic Receptor Endocytosis in Sympathetic Neurons via Protein Kinase A and Spinophilin* , 2013, The Journal of Biological Chemistry.

[22]  J. García-Sevilla,et al.  α 2-Adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression , 1992, Biological Psychiatry.

[23]  J. Guimón,et al.  Alpha 2-adrenoceptor-mediated inhibition of platelet adenylate cyclase and induction of aggregation in major depression. Effect of long-term cyclic antidepressant drug treatment. , 1990, Archives of general psychiatry.

[24]  B. McEwen,et al.  Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. , 1986, Archives of general psychiatry.

[25]  L. Flyckt,et al.  Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram , 1985, European Journal of Clinical Pharmacology.

[26]  G. Breese,et al.  Rapid down regulation of beta adrenergic receptors by combining antidepressant drugs with forced swim: a model of antidepressant-induced neural adaptation. , 1985, The Journal of pharmacology and experimental therapeutics.

[27]  J. Nomura,et al.  Interaction betweenα2- and β-adrenergic receptors in rat cerebral cortical membranes: clonidine-induced reduction in agonist and antagonist affinity for β-adrenergic receptors , 1991, Brain Research.

[28]  M R Crompton,et al.  Beta-adrenoceptors in human brain labelled with [3H]dihydroalprenolol and [3H]CGP 12177. , 1989, European journal of pharmacology.

[29]  C. Montigny,et al.  Electrophysiologic Evidence for Desensitization of α2-Adrenoceptors on Serotonin Terminals Following Long-Term Treatment with Drugs Increasing Norepinephrine Synaptic Concentration , 1994, Neuropsychopharmacology.

[30]  J. García-Sevilla,et al.  Characterization and Regional Distribution of α2‐Adrenoceptors in Postmortem Human Brain Using the Full Agonist [3H]UK 14304 , 1989, Journal of neurochemistry.

[31]  Á. Pazos,et al.  Selective Increase of α2A‐Adrenoceptor Agonist Binding Sites in Brains of Depressed Suicide Victims , 1998, Journal of neurochemistry.

[32]  C. Udina,et al.  Enhanced binding of [3H] (‐) adrenaline to platelets of depressed patients with melancholia: Effect of long‐term clomipramine treatment , 1987, Acta psychiatrica Scandinavica.

[33]  S. Esteban,et al.  Activation and desensitization by cyclic antidepressant drugs of α2-autoreceptors, α2-heteroreceptors and 5-HT1A-autoreceptors regulating monoamine synthesis in the rat brain in vivo , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[34]  José Guimón,et al.  Relationships between β- and α2-adrenoceptors and G coupling proteins in the human brain: effects of age and suicide , 2001, Brain Research.

[35]  J. Zarranz,et al.  Decreased Density of Presynaptic α2‐Adrenoceptors in Postmortem Brains of Patients with Alzheimer's Disease , 1992, Journal of neurochemistry.

[36]  S. Hjorth,et al.  Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats. , 1999, Clinical neuropharmacology.

[37]  J. Blendy The Role of CREB in Depression and Antidepressant Treatment , 2006, Biological Psychiatry.

[38]  E. Paykel,et al.  The role of noradrenaline and selective noradrenaline reuptake inhibition in depression , 2002, European Neuropsychopharmacology.

[39]  C. Aoki,et al.  Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons. , 1998, Cerebral cortex.

[40]  Yogesh K. Dwivedi,et al.  Noradrenergic Function in Suicide , 2007, Archives of suicide research : official journal of the International Academy for Suicide Research.

[41]  C. Katona,et al.  Brainβ-adrenoceptor binding sites in depressed suicide victims: effects of antidepressant treatment , 2005, Psychopharmacology.

[42]  M. Tabaton,et al.  Adrenergic Receptors in Aging and Alzheimer's Disease: Increased β2‐Receptors in Prefrontal Cortex and Hippocampus , 1989, Journal of neurochemistry.

[43]  J. Vetulani,et al.  Enhancement of the responsiveness of cortical adrenergic receptors by chronic administration of the 5‐hydroxytryptamine uptake inhibitor citalopram. , 1993, Journal of neurochemistry.

[44]  Á. Pazos,et al.  Alpha 2-adrenoceptor subtypes in the human brain: a pharmacological delineation of [3H]RX-821002 binding to membranes and tissue sections. , 1996, European journal of pharmacology.

[45]  P. Goldman-Rakic,et al.  Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System. , 1995, Cerebral cortex.

[46]  D. Heal,et al.  Antidepressant Treatments, Including Sibutramine Hydrochloride and Electroconvulsive Shock, Decrease β1 but Not β2‐Adrenoceptors in Rat Cortex , 1989 .

[47]  V. Arango,et al.  Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. , 1990, Archives of general psychiatry.

[48]  A. Maggi,et al.  beta-Adrenergic regulation of alpha 2-adrenergic receptors in the central nervous system. , 1980, Science.

[49]  M. Scheinin,et al.  Recombinant human alpha 2-adrenoceptor subtypes: comparison of [3H]rauwolscine, [3H]atipamezole and [3H]RX821002 as radioligands. , 1995, Biochimica et biophysica acta.

[50]  Qin Wang,et al.  α2 adrenergic receptor dysregulation in depressive disorders: Implications for the neurobiology of depression and antidepressant therapy , 2012, Neuroscience & Biobehavioral Reviews.

[51]  A. Biegon,et al.  Regionally selective increases in β-adrenergic receptor density in the brains of suicide victims , 1988, Brain Research.

[52]  Y. Mateo,et al.  Acute and chronic effects of desipramine and clorgyline on α2‐adrenoceptors regulating noradrenergic transmission in the rat brain: a dual‐probe microdialysis study , 2001, British journal of pharmacology.